It’s not easy to get depression-detecting AI through the FDA
📰 The Verge
Kintsugi, a startup developing AI for depression detection, shuts down due to FDA clearance issues
Action Steps
- Develop AI models for detecting depression and anxiety from speech patterns
- Understand FDA clearance requirements for healthcare AI technologies
- Explore open-source release of AI technology to benefit the broader community
Who Needs to Know This
AI engineers and data scientists on healthcare-focused teams can learn from Kintsugi's challenges, while product managers and entrepreneurs can understand the regulatory hurdles in the industry
Key Insight
💡 FDA clearance is a significant regulatory challenge for healthcare AI startups
Share This
🚨 AI for depression detection faces FDA hurdles 🚨
DeepCamp AI